Previous Close | 2.2900 |
Open | 2.2900 |
Bid | 1.8500 |
Ask | 3.4000 |
Strike | 7.50 |
Expire Date | 2024-12-20 |
Day's Range | 2.2900 - 2.2900 |
Contract Range | N/A |
Volume | |
Open Interest | 20 |
CHASKA, Minn., May 22, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization, today announced that Lifecore has granted a restricted stock unit (“RSU”) award with respect to 525,000 shares of its common stock and a performance stock unit (“PSU”) award for up to 1,500,000 shares of its common stock to Paul Josephs, Lifecore’s newly hired President and Chief Executive Officer. The RSU
Recent Initiatives Provide Approximately $8 Million of Non-Dilutive, Incremental Liquidity through Various Amendments with LendersCHASKA, Minn., May 16, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), announced certain incremental liquidity measures and housekeeping matters related to divested businesses through a series of 8-K filings over the past week. James G. Hal
In this article we are going to reveal the names of 10 stocks that are on hedge funds’ radar. The US market sustained strong performance in the first quarter of 2024 as the S&P Index increased by 10.6%, continuing its momentum from the previous quarter. There is a prevailing optimism in the market regarding a […]